BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12769041)

  • 1. [A new product in the vaccination gap: the vector vaccine. Merial introduced an innovative influenza-tetanus vaccine for horses].
    Hulsen J
    Tijdschr Diergeneeskd; 2003 May; 128(9):295-6. PubMed ID: 12769041
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis in the horse.
    Ardans AA
    J Am Vet Med Assoc; 1982 Nov; 181(10):1150-3. PubMed ID: 6294030
    [No Abstract]   [Full Text] [Related]  

  • 4. [Simple, simultaneous or combined vaccinations of horses against equine influenza, rabies and tetanus (author's transl)].
    Brun A; Duret C; Devaux B; Calmels D
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):93-9. PubMed ID: 6258854
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authors do not believe article provides evidence of vaccine efficacy.
    Morley PS; Townsend HG; Haines DM
    Am J Vet Res; 2001 May; 62(5):648. PubMed ID: 11341378
    [No Abstract]   [Full Text] [Related]  

  • 7. [A practical horse and pony health programme: prevention of parasitic and infectious disease (author's transl)].
    Verberne LR; Mirck MH
    Tijdschr Diergeneeskd; 1974 Oct; 99(19):1004-10. PubMed ID: 4408438
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficiency of equine influenza vaccines including tetanus toxoid of combined vaccines].
    Bommeli W; Kihm U; Löhrer J; Fey H
    Schweiz Arch Tierheilkd; 1980 Jan; 122(1):27-37. PubMed ID: 7384775
    [No Abstract]   [Full Text] [Related]  

  • 9. Questions validity of equine vaccine field studies.
    Piontkowski MD
    J Am Vet Med Assoc; 1999 Sep; 215(5):620-1. PubMed ID: 10476701
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.
    Wilson WD; Mihalyi JE; Hussey S; Lunn DP
    Equine Vet J; 2001 Nov; 33(7):644-50. PubMed ID: 11770984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined vaccination plan against influenza, equine rhinopneumonitis and tetanus for thoroughbred horses].
    Bürki F
    Dtsch Tierarztl Wochenschr; 1976 Mar; 83(3):89-92. PubMed ID: 183944
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for vaccination of horses. The American Association of Equine Practitioners' Vaccination Guidelines Subcommittee of the AVMA Council on Biologic and Therapeutic Agents.
    J Am Vet Med Assoc; 1995 Aug; 207(4):426-31. PubMed ID: 7591939
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
    Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
    Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines.
    Mumford JA; Jessett DM; Rollinson EA; Hannant D; Draper ME
    Vet Rec; 1994 Feb; 134(7):158-62. PubMed ID: 8160328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination of horses against equine influenza using a polyvalent inactivated vaccine].
    Cottereau P; Petermann HG; Fayet MT; Papageorgiou C; Valette L; Vicaria JM
    Bull Acad Vet Fr; 1969 Apr; 42(4):141-6. PubMed ID: 5408039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.